Piper Sandler has reduced CVS Health's price target to $64 from $72 but maintains an Overweight rating. They anticipate margin expansion and growth for CVS, with strong prospects for Aetna MA franchise. Trump's policies on EV tax credit and healthcare are also discussed.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing